UK markets open in 4 hours 44 minutes
NIKKEI 225
38,317.13 +764.97 (+2.04%) HANG SENG
16,958.29 +129.36 (+0.77%) CRUDE OIL
83.31 -0.05 (-0.06%) GOLD FUTURES
2,331.30 -10.80 (-0.46%) DOW
38,503.69 +263.71 (+0.69%) Bitcoin GBP
53,536.71 -167.68 (-0.31%)
Agios Pharmaceuticals, Inc. (AGIO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 30.21 |
| Open | 30.40 |
| Bid | 31.69 x 100 |
| Ask | 32.02 x 100 |
| Day's range | 30.40 - 33.02 |
| 52-week range | 19.80 - 35.50 |
| Volume | |
| Avg. volume | 762,496 |
| Market cap | 1.788B |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Director Jacqualyn Fouse Sells Shares of Agios Pharmaceuticals Inc (AGIO)
Agios Pharmaceuticals Inc (NASDAQ:AGIO), a biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of cancer and rare genetic diseases, has seen a recent insider transaction according to the latest SEC filings.
- Simply Wall St.
We Think Agios Pharmaceuticals (NASDAQ:AGIO) Can Afford To Drive Business Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
- Investor's Business Daily
Agios Pharmaceuticals Stock Earns IBD Stock Upgrade Again, Hitting 90-Plus RS Rating
Agios Pharmaceuticals stock had its Relative Strength (RS) Rating upgraded from 84 to 91 Monday. When looking for the best stocks to buy and watch, keep a close on eye on relative price strength. Is Agios Pharmaceuticals Stock A Buy?
© 2024 Yahoo. All rights reserved.